Topic summary

Restarting after a long gap: what the labelling implies

Practice › Dosing & titration dose reduction semaglutide titration missed dose worked example

This is a generated summary. It shows the 7 most-liked posts from a topic of 47, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

endpoint_lineTL3Regular27 Jun 2026#3

r.bruun, post #1: Posting this under the heading it deserves: Restarting after a long gap: what the labelling implies Everything below is what sits behind that. I have read the maintained page on this and I still have a gap, so I am asking rather than guessing. Context: tirzepatide, 14 weeks in, currently at a dose I reached by the standard four-week… Go to post

Picking up post #2: that is the part I would want checked first.

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

23 likes in reply to #1 1mo

d.ndiayeTL2 Moderator1 Jul 2026#8

I read post #6 twice before replying, because I had assumed the opposite.

Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you stay at an intermediate dose for years is not formally studied and extrapolation is the best available reasoning.

31 likes 27d

b.correiaTL2 Moderator5 Jul 2026#13

Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a weekly dosing schedule. Splitting it flattens the curve further but loses the convenience of once-weekly dosing. The trade-off is convenience versus a slightly flatter concentration curve.

32 likes 22d

c.serranoTL2 Moderator8 Jul 2026#17

24 likes 20d

r.girardTL2 Moderator12 Jul 2026#22

Coming back to post #20, because the follow-up matters more than the original answer.

Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that stepping down is followed by some regain, with the magnitude unknown.

24 likes in reply to #1 16d

unit_conversionTL3Regular20 Jul 2026#35

a.eriksen, post #15: The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The reasoning is pharmacological — e.g., "I will split the difference between steps" — but it is reasoning from theory, not from evidence. Go to post

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

30 likes in reply to #15 8d

ar.kravchenkoTL2 Moderator24 Jul 2026#42

27 likes 4d

Read the full topic (47 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Practice › Dosing & titration dose reduction semaglutide titration Wiki Posting this under the heading it deserves: Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Everything below is what sits behind that. Reporting something rather than…	+138	148	1.8k	2y
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Practice › Dosing & titration missed dose tirzepatide dose reduction titration Solved Asking directly, because I could not find a straight answer: Reaching a dose and staying there for a year: a longitudinal note — does this still hold? I have read the maintained page on this and I still have…	+35	39	547	11mo
How the published trials escalated, tabulated side by side — does this still hold? Practice › Dosing & titration dose reduction tirzepatide missed dose Solved Asking directly, because I could not find a straight answer: How the published trials escalated, tabulated side by side — does this still hold? A question about technique rather than about dose. I have been…		2	8.9k	9mo
When a dose reduction is the correct response to a side effect — a second dataset Practice › Dosing & titration worked example dose reduction titration tirzepatide When a dose reduction is the correct response to a side effect — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on…	+10	14	42k	2mo
Follow-up: Escalating every six weeks instead of four: what I observed over eight months Practice › Dosing & titration titration worked example tirzepatide dose reduction Escalating every six weeks instead of four: what I observed over eight months — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have…		4	164	20mo

Related topics — sharing the tags dose reduction, semaglutide, titration

Topic	Participants	Replies	Views	Activity
Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes Devices › Pens & autoinjectors dead volume missed dose storage subcutaneous injection Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this…		2	18k	6h
Reading a syringe in poor light, and how to avoid needing to — what changed since Devices › Syringes & needles dead volume subcutaneous injection syringe units needle gauge & length Posting this under the heading it deserves: Reading a syringe in poor light, and how to avoid needing to — what changed since Everything below is what sits behind that. I have read the maintained page on this…	+3	7	27k	27d
Dead volume across syringe and needle combinations Devices › Syringes & needles needle gauge & length subcutaneous injection dead volume syringe units On the subject in the title: Dead volume across syringe and needle combinations Working notes rather than a conclusion. Practical question with the units stated, because I have seen how quickly these go wrong…	+72	80	28k	5mo
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept Practice › Dosing & titration dose reduction worked example tirzepatide missed dose Solved Asking directly, because I could not find a straight answer: Why "dose equivalence" between different incretin analogues is a weak concept Reporting something rather than asking about it, in case the pattern…	+7	11	26k	9mo
Follow-up: Dead volume across syringe and needle combinations Devices › Syringes & needles syringe units worked example subcutaneous injection dead volume Solved Dead volume across syringe and needle combinations — setting out what I have, and where I think it stops being reliable. Practical question with the units stated, because I have seen how quickly these go…	+81	98	22k	18mo